Equine Healthcare Market at a CAGR of 4.3% from 2021 to 2030

Equine Healthcare Market Outlook 2028

The global equine healthcare market was valued at US$ 698.7 Mn in 2020

It is estimated to expand at a CAGR of 4.3% from 2021 to 2028

The global equine healthcare market is expected to cross the value of US$ 972.8 Mn by the end of 2030

Get the sample copy of report@ https://qyresearchmedical.com/sample/111780

Analysts’ Viewpoint on Equine Healthcare Market Scenario

Equine practitioners are practicing strict biosecurity at all farms, performance venues, racetracks, and the likes during the ongoing COVID-19 pandemic. It has been found that issues of recurring common horse healthcare problems are affecting market growth. Hence, stakeholders in the equine healthcare market should increase awareness about regular de-worming schedules and professional veterinary advice to reduce the incidence of recurring common horse healthcare problems. Therapeutics such as corticosteroids are being extensively used as joint injections. Bisphosphonates such as tiludronate disodium (Tildren) and clondronate (Osphos) are labelled for controlling clinical signs associated with navicular syndrome. There is a need for research surrounding bisphosphonate use in horses under the age of four.

Comprehensive Equine Vaccine Portfolio Creates Revenue Opportunities for Manufacturers

Equine practitioners are performing a risk-benefit analysis to determine if a horse should receive a particular risk-based vaccine. This is necessary since extra vaccinations can be costly and can cause unnecessary stress to the horse. Manufacturers in the equine healthcare market are increasing the production of vaccines to improve clinical numbers. With the help of risk-benefit analysis, veterinarians are educating horse owners about different types of risk-based vaccines such as equine influenza and strangles vaccines for horses active at events.

Manufacturers in the equine healthcare market are developing the anthrax vaccine for horses that live in an area where spores are known to thrive in the soil. On the other hand, pregnant mares during specific months of pregnancy are advised to receive certain risk-based vaccines. Companies are developing a diverse portfolio in vaccine such as the equine herpesvirus, botulism and rotaviral diarrhea.

AVMA Draws Guidance for Equine Veterinarians amid Ongoing COVID-19 Pandemic

Apart from ensuring healthcare services for horses, the COVID-19 pandemic has drawn attention to the wellbeing of equine veterinarians. Stakeholders in the equine healthcare market are taking cues from the AVMA (American Veterinary Medical Association) such as following the hierarchy of controls to reduce the spread of the novel infection among equine practitioners.

While PPE (personal protective equipment) serves as an important protective function, the optimal way to prevent disease transmission is to use a combination of interventions from across the hierarchy of controls. Participants in the equine healthcare market are re-scheduling non-urgent veterinary procedures. They are considering telemedicine as an alternative to in-person visit.

Professional Veterinary Intervention Helps Overcome Recurring Common Horse healthcare Problems

Common horse healthcare problems such as laminitis or thrush can leave a horse more likely to contract it again. Hence, participants in the market are educating horse owners to seek professional veterinary advice and veterinary intervention to improve clinical outcomes.

The high prevalence of allergies, colic, and mud fever, among other common horse healthcare problems, is triggering the demand for healthcare services. Such findings are contributing to the growth of the equine healthcare market. Problems of worms, sweet itch and back problems are translating into revenue opportunities for market stakeholders.

Wearables Enable Early Indication of healthcare Issues in Horses

Apart from drugs, vaccines and supplemental feed additives, market stakeholders are boosting R&D in the equestrian sports technology such as wearables for horses. As such, there is a need for validated approaches of consistently and regularly tracking healthcare parameters such as temperature, heart rate, and respiratory rates. Thus, wearable devices hold promising potentials to offer these statistics.

The data gathered by wearable devices has the ability to give an earlier indication of issues, which may require veterinary investigation. Such innovations are translating into incremental opportunities for med-tech companies in the equine healthcare market.

Safety and Welfare of Horses Crucial While Innovating in Therapeutics

In the racing industry, medication use has changed drastically over the years, as manufacturers develop new drugs whilst scientists hone techniques they use to analyze and identify therapeutic medications. healthcare companies are focusing on maintaining a level playing field, protecting the safety of the horse, and protecting the betting public. As such, companies are boosting the production of corticosteroids, NSAIDs, and bisphosphonates, among other drugs.

Racing regulators have historically permitted NSAID use within 24-hrs of race time. However, in the recent times, there have been recommendations to increase the timeframe to no earlier than 48-hrs.

Equine Healthcare Market: Overview

The global equine healthcare market for the historical period 2017–2019 and forecast period 2021–2028, strong impact of the equine industry on the economy is projected to drive the global equine healthcare market during the forecast period

Strong Impact of Equine Industry on Economy: Key Driver

The equine industry involves breeding, keeping, and overall management of horses. It has a strong impact on the overall economy. The industry creates income opportunities for several veterinary physicians, equestrians, and others. Additionally, it involves a supply demand scenario of equine healthcare products. Strong economic impact of the equine industry is expected to drive the global equine healthcare market.

High Incidence of Equine Infections: Major Driver

Horse breeding is a core activity in the equine industry. Hence, choice of breeding stock and better healthcare management of breeds are crucial to improve breeding operations. Occurrence of equine infections is another major concern for the breeders. For instance, South America and the Caribbean have high incidence of Potomac horse fever.

The West Nile Virus infection among horses has been controlled; however, sudden emergence of the virus can cause concerns among horse owners. Moreover, tetanus and equine influenza cases are evident among the global horse community. Hence, high incidence of equine infections is likely to drive the global equine healthcare market.

Decline in Global Equine Population to Hamper Market

The global equine healthcare market has strong correlation with the global equine population

According to a research, the horse population in the Americas declined by 5.37% in the past five years, while the horse population declined by 7.47% during the same period

Hence, fall in the global horse population is likely to restrain the global equine healthcare market during the forecast period

Equine Healthcare Market: Competition Landscape

This report profiles major players in the global equine healthcare market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global equine healthcare market is highly fragmented, with the presence of a number of international as well as regional players

Leading players operating in the global equine healthcare market are

  • Bayer AG (Bayer Animal healthcare)
  • Boehringer Ingelheim
  • Ceva Santé Animale
  • Eli Lilly and Company (Elanco)
  • Equine Products UK Ltd.
  • Merck & Co. (Merck Animal healthcare)
  • Sanofi (Merial)
  • Purina Animal Nutrition LLC.
  • Vetoquinol S.A.
  • Zoetis

Key Questions Answered in Equine Healthcare Market Report

  • What is the scope of growth of companies in the global equine healthcare market?
  • What will be the Y-o-Y growth of the global equine healthcare market between 2017 and 2028?
  • What is the influence of changing trends in technologies on the global equine healthcare market?
  • Which factors are anticipated to hamper the growth of the global equine healthcare market during the forecast period?
  • Which are the leading companies in the global equine healthcare market?

Equine Healthcare Market – Segmentation

Product Type

  • Drugs
  • Anti-infectives
  • Anti-inflammatory
  • Parasititidis
  • Others
  • Vaccines
  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others
  • Supplemental Feed additives
  • Proteins & Amino Acids
  • Vitamins
  • Enzymes
  • Minerals
  • Others

Disease Type

  • Equine Influenza
  • Rhinopneumonitis/Equine Herpes Virus (EHV)
  • Equine Encephalomyelitis (Sleeping Sickness)
  • Equine Infectious Anemia (EIA)
  • West Nile Virus
  • Equine Rabies
  • Potomac Horse Fever
  • Tetanus (Lockjaw)
  • Others

Distribution Channel

  • Veterinary Hospitals & Clinics
  • Pharmacies & Drug Stores
  • Others


  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111780/2900

Leave a Reply

Your email address will not be published. Required fields are marked *